22 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
Pediatric Oncology Leadership Team where she oversaw multiple oncology clinical programs. She has replaced Raphaël Rousseau, MD, PhD, who has transitioned … Grossman to its Board of Directors. Both individuals bring deep expertise and leadership in oncology to the Company’s Board.
The recommended Phase 2
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
17 Jan 24
Day One Announces Two New Appointments to Board of Directors
8:25am
of Day One. “Their deep expertise and leadership in oncology will further strengthen our Board and will be a great asset as we prepare for the potential … to join the Board of Day One at such an important time,” said Habib Dable. “I look forward to partnering with the executive leadership team and the Board
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Leadership team strengthened with executive appointments in clinical … industry veterans to Day One’s executive leadership team. Lauren Merendino will join as Chief Commercial Officer and Dr. Raphaël Rousseau will join
PRE 14A
8yqylq0hcl19x7 52
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
2zfmucxmwbyas0cglm1k
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
y8mbug3g
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.1
a87egm
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
DEF 14A
kao64g
28 Apr 22
Definitive proxy
4:44pm
10-K
q1dpkhtfk67cg0
7 Mar 22
Annual report
7:36am
8-K
EX-99.1
lnjuun
8 Nov 21
Day One Reports Third Quarter 2021 Financial Results and Corporate Progress
4:51pm
8-K
EX-99.1
eeiz6tv173u9
17 Aug 21
Day One Appoints Scott Garland to Board of Directors
7:17am
8-K
EX-99.2
vqqkn v6gx
10 Aug 21
Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
4:15pm
424B4
dkb88jdcv
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
96ec keixyc
24 May 21
IPO registration (amended)
6:16am
S-1
vn0pyav73i963p
4 May 21
IPO registration
4:12pm
CORRESP
4p4 9x7mlp6l8c
4 May 21
Correspondence with SEC
12:00am